Jpmorgan Chase & CO Agios Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,712,990 shares of AGIO stock, worth $55.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,712,990

Previous 1,776,145 3.56%

Holding current value

$55.1 Million

Previous $76.6 Million 0.63%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	SELL	$41.19 - $49.72 $2.6 Million - $3.14 Million	-63,155 Reduced 3.56%	1,712,990 $76.1 Million
Q3 2024 Nov 08, 2024	SELL	$41.19 - $49.72 $2.6 Million - $3.14 Million	-63,155 Reduced 3.56%	1,712,990 $76.1 Million
Q2 2024 Dec 26, 2024	BUY	$27.55 - $48.83 $1.74 Million - $3.08 Million	63,155 Added 3.69%	1,776,145 $76.6 Million
Q2 2024 Aug 12, 2024	SELL	$27.55 - $48.83 $19.2 Million - $34 Million	-696,545 Reduced 28.17%	1,776,145 $76.6 Million
Q1 2024 Dec 26, 2024	BUY	$21.32 - $34.81 $16.2 Million - $26.4 Million	759,700 Added 44.35%	2,472,690 $72.3 Million
Q1 2024 May 10, 2024	SELL	$21.32 - $34.81 $1.49 Million - $2.44 Million	-70,056 Reduced 2.76%	2,472,690 $72.3 Million
Q4 2023 Dec 26, 2024	BUY	$19.97 - $24.53 $16.6 Million - $20.4 Million	829,756 Added 48.44%	2,542,746 $56.6 Million
Q4 2023 Feb 12, 2024	BUY	$19.97 - $24.53 $1.5 Million - $1.84 Million	74,925 Added 3.04%	2,542,746 $56.6 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $612,751 - $708,839	-25,154 Reduced 1.01%	2,467,821 $61.1 Million
Q2 2023 Aug 11, 2023	BUY	$21.38 - $29.19 $27.7 Million - $37.8 Million	1,294,462 Added 108.01%	2,492,975 $70.6 Million
Q1 2023 May 18, 2023	BUY	$21.74 - $30.93 $1.49 Million - $2.13 Million	68,717 Added 6.08%	1,198,513 $27.5 Million
Q1 2023 May 11, 2023	SELL	$21.74 - $30.93 $1.15 Million - $1.64 Million	-53,029 Reduced 4.48%	1,129,796 $26 Million
Q4 2022 Feb 13, 2023	SELL	$24.81 - $31.52 $7.54 Million - $9.57 Million	-303,770 Reduced 20.43%	1,182,825 $33.2 Million
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $1.5 Million - $2.62 Million	76,859 Added 5.45%	1,486,595 $42 Million
Q2 2022 Aug 11, 2022	SELL	$17.06 - $31.42 $31.8 Million - $58.6 Million	-1,865,656 Reduced 56.96%	1,409,736 $31.3 Million
Q1 2022 May 11, 2022	BUY	$26.68 - $34.81 $4.67 Million - $6.09 Million	174,982 Added 5.64%	3,275,392 $95.3 Million
Q4 2021 Feb 10, 2022	SELL	$29.58 - $49.78 $33.8 Million - $56.9 Million	-1,142,575 Reduced 26.93%	3,100,410 $102 Million
Q3 2021 Nov 12, 2021	BUY	$41.92 - $58.18 $178 Million - $247 Million	4,242,985 New	4,242,985 $196 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.76B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Agios Pharmaceuticals, Inc. Transaction History